• Tutorial
  • Product Matrix
  • Validate
  • Regulatory
  • ROI
  • News
  • Blog
  • Events
  • References
  • LinkedIn Group
  • Training & Consulting
  • Contact

Rapid Micro Methods News

Our news pages will keep you informed of press releases and news articles on RMM technologies, updates from technology suppliers, reviews of recent publications and presentations, and what's changing in the world of rapid methods. You can also follow our news posts on Twitter, Facebook, LinkedIn and RSS.

Follow us on Twitter Follow us on Facebook LinkedIn RSS Feed

Please click here to submit your news

Friday, October 24, 2014

Ebola Detection Using Rapid Tests and ELISA Kits for Humans and Animals

San Antonio, Texas-based Biotech Company Alpha Diagnostic Int'l (ADI) has developed and released several convenient, rapid, and sensitive ELISA test kits for the detection of major Ebola viral protein antibodies (Glycoprotein, GP; Nucleoprotein, NP, and Viral Protein 40 or VP40).  The antibody ELISA kits are available not only for human samples but also for monkey, dog and mouse as some of the Ebola vaccines are first tested in the animal and primate model.

Dr. Kent Brantly, the first American to return to the U.S. from Liberia and then survive Ebola, has donated blood for transfusions to other patients, including Nurse Nina Pham who contracted Ebola while taking care of a Liberian patient who succumbed to Ebola.  ADI’s Ebola virus antibody ELISA kits can be used to determine if Dr. Brantly, or any other potential Ebola survivors, actually has the antibodies prior to giving a blood donation.  “More importantly, a population survey can be done to determine the immunity levels of Ebola in endemic regions,” said Dr. Masarrat Ali, Director of ADI.  The levels of antibodies sufficient enough to provide immunity also need to be established.  ADI has made similar antibody kits for dog and pig to establish if the animals from Ebola endemic regions have any circulating Ebola virus protein antibodies and, therefore, exposed to Ebola virus.  The antibody ELISA kits are highly sensitive and need only a tiny drop of blood or serum to conduct the test within two hours.

The United States, United Kingdom, and Canada have started clinical trials on the most promising candidates for Ebola vaccines.  These vaccines use an adenovirus (chAd3) or vesicular stomatitis virus (VSV) vectors to deliver one of the most antigenic Ebola virus’s Glycoprotein (GP) in order to induce antibodies in humans or primates.  “ADI’s Ebola virus GP antibody ELISA tests along with the chAd3 and VSV protein antibody ELISA kits will allow for immediate assessment of vaccine efficacy,” said Dr. Ali.

Zmapp, an experimental therapeutic cocktail of three humanized GP monoclonal antibodies, has been used in some Ebola patients in order to neutralize the Ebola virus.  The U.S. Department of Health and Human Services has provided $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate the development and testing of ZMapp.  ADI has developed ELISA kits to not only measure the Zmapp antibody concentration in its purified form but also after infusion to humans or animals.  For example, it is possible to establish the levels of Zmapp in Dr. Brantly’s blood immediately after the first dose and then weeks and months afterwards.  It is also now possible to assess what levels of Zmapp, natural antibodies, or antibodies induced by vaccines are sufficient to prevent an Ebola infection. The Ebola antibodies test is conducted in less than two hours in a laboratory in field setting with minimal instruments or equipment.

Additional rapid tests, similar to pregnancy tests, have been developed to quickly identify and assess the activity of Zmapp in 2-5 minutes.  “These tests will not only help in the manufacturing and quality control of Zmapp but also prevent any fraudulent marketing of the drug,” said Dr Ali.

ADI has also developed the Ebola virus GP antigen and antibody rapid tests to quickly help identify potential exposure to the virus.  The rapid tests, when approved by FDA, can be used in field settings, doctors' offices, pharmacies, airports, or borders.  The tests require no instruments and can be used by any laboratory personnel.  ADI is the first company to develop and release a number of Ebola tests.  ADI is contacting the CDC and health officials in Texas to donate some of these kits.  “The availability of these kits should help diagnose Ebola in humans and animals and allow for rapid testing of various Ebola vaccines,” said Dr. Ali.
Posted by RapidMicro at 8:49 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
  • Click to Show All News Articles

Search for News





News Archive

  • ►  2019 (10)
    • ►  February (6)
    • ►  January (4)
  • ►  2018 (187)
    • ►  December (9)
    • ►  November (16)
    • ►  October (15)
    • ►  September (14)
    • ►  August (18)
    • ►  July (9)
    • ►  June (24)
    • ►  May (13)
    • ►  April (15)
    • ►  March (20)
    • ►  February (19)
    • ►  January (15)
  • ►  2017 (115)
    • ►  December (9)
    • ►  November (15)
    • ►  October (10)
    • ►  September (8)
    • ►  August (17)
    • ►  July (12)
    • ►  June (5)
    • ►  May (4)
    • ►  April (11)
    • ►  March (6)
    • ►  February (12)
    • ►  January (6)
  • ►  2016 (127)
    • ►  December (12)
    • ►  November (17)
    • ►  October (11)
    • ►  August (19)
    • ►  July (7)
    • ►  June (16)
    • ►  May (13)
    • ►  April (7)
    • ►  March (8)
    • ►  February (17)
  • ►  2015 (187)
    • ►  December (12)
    • ►  November (12)
    • ►  October (17)
    • ►  September (20)
    • ►  August (10)
    • ►  July (20)
    • ►  June (7)
    • ►  May (11)
    • ►  April (19)
    • ►  March (21)
    • ►  February (23)
    • ►  January (15)
  • ▼  2014 (199)
    • ►  December (22)
    • ►  November (16)
    • ▼  October (28)
      • Swiss Firm, May & Baker Partner on Rapid Genetic T...
      • Canadian Company Develops 60-Second Ebola Testing ...
      • South Bend, IN Company Developing Rapid Ebola Dete...
      • Chembio and Integrated BioTherapeutics to Develop ...
      • Roche Seeks Fast-Track for Ebola Diagnostic Test
      • U.S. FDA Now Issues Emergency Authorization for Tw...
      • Diagnostic Tests Key to Helping Swine Producers Fi...
      • Paper-based Synthetic Gene Networks Could Enable R...
      • Genalyte Develops 10-Minute Ebola Test
      • Ebola Detection Using Rapid Tests and ELISA Kits f...
      • US Army Infectious Disease Unit Supports Ebola Vir...
      • A Handheld Device that Detects Malaria in 30 Minut...
      • New Test Accelerates Herpes Detection
      • IAEA Joins Effort to Stem Ebola Outbreak
      • Rapid Diagnostic Tests Performed Poorly in Detecti...
      • NanoLogix Technology Being Configured For Rapid Eb...
      • Quidel Receives FDA Clearance for Its Lyra® Molecu...
      • OraSure Approached About Developing Ebola Test Kit...
      • BioVigilant Introduces Instantaneous Microbial Det...
      • RPS Announces CE Mark of Rapid Point-Of-Care Test ...
      • PositiveID and ENSCO Awarded Contract for U.S. Dep...
      • BioInnovation Solutions and USAMRIID Develop DNA S...
      • Primerdesign Develops Simple Diagnostic Test Solut...
      • HHS Pursues Detection Tests for Influenza
      • Entamoeba histolytica Rapid Test Receives CE Mark
      • Neogen Acquires BioLumix
      • Auburn University and Keesler Air Force Base Colla...
      • Alere Awarded U.S. Government Contract to Advance ...
    • ►  September (19)
    • ►  August (11)
    • ►  July (13)
    • ►  June (11)
    • ►  May (17)
    • ►  April (13)
    • ►  March (13)
    • ►  February (19)
    • ►  January (17)
  • ►  2013 (229)
    • ►  December (14)
    • ►  November (20)
    • ►  October (15)
    • ►  September (18)
    • ►  August (8)
    • ►  July (31)
    • ►  June (21)
    • ►  May (18)
    • ►  April (22)
    • ►  March (20)
    • ►  February (15)
    • ►  January (27)
  • ►  2012 (262)
    • ►  December (17)
    • ►  November (26)
    • ►  October (18)
    • ►  September (15)
    • ►  August (22)
    • ►  July (18)
    • ►  June (29)
    • ►  May (23)
    • ►  April (26)
    • ►  March (29)
    • ►  February (20)
    • ►  January (19)
  • ►  2011 (180)
    • ►  December (19)
    • ►  November (15)
    • ►  October (23)
    • ►  September (15)
    • ►  August (20)
    • ►  July (13)
    • ►  June (24)
    • ►  May (16)
    • ►  April (10)
    • ►  March (3)
    • ►  February (14)
    • ►  January (8)
  • ►  2010 (53)
    • ►  December (7)
    • ►  November (8)
    • ►  October (9)
    • ►  September (15)
    • ►  August (3)
    • ►  July (3)
    • ►  June (8)

Popular News Articles

  • Abbott Discontinuing Current Version of Plex-ID PCR System for Smaller Platform Under Development
    Abbott is discontinuing the current version of the Plex-ID system as it prepares for market a next-generation system intended to be smaller...
  • FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening Test for Syphilis
    The U.S. Food and Drug Administration today announced that it granted the first-ever waiver, under certain laboratory regulations, for a rap...
  • DNA Extraction from Samples in a Minute
    Scientists at the Agharkar Research Institute (ARI) in Pune have developed a novel technology to extract bacterial DNA in just a minute from...
  • RPS Announces CE Mark of Rapid Point-Of-Care Test to Help Detect the Body's Immune Response to Viral And Bacterial Infections
    RPS Diagnostics Inc. (RPS®) announced CE mark of its FebriDx™ test clearing the way for sales in the European Union and all countries recogn...
  • Chembio Signs Agreement With CDC Contractor to Develop a Multiplex Point-of-Care Test for Influenza Immunity
    Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered int...
  • A High-Tech Real-Time Solution for Detecting Bacteria in Water
    Water quality and safety can never be taken for granted. Every day, millions of tons of inadequately treated sewage, industrial and agricult...
  • Escherichia coli Serotype O104:H4 Quality Control Strain Now Available from Microbiologics
    Leading biomaterial manufacturer, Microbiologics, has added a new strain of Shiga-toxin producing Escherichia coli (STEC) to their line o...
  • 3M Debuts Food Safety Molecular Detection Assay for Listeria monocytogenes
    The new 3M molecular detection assay for Listeria monocytogenes is the fourth test available for the 3M molecular detection system, which ...
  • MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing
    MilliporeSigma today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens grow...
  • Devices for Detecting Pathogens in Food on the Production Line
    CIC microGUNE is developing the PREDETEC project, which aims to produce sensors capable of locating infectious agents in food, thanks to the...

Links

  • Microbiology Consultants, LLC
© Copyright 2010-2019 rapidmicromethods.com. All rights reserved. • Terms of Use • Advertise
LinkedIn  LinkedIn   Follow RapidMicro on Twitter  Twitter   Follow RapidMicro on Facebook  Facebook